Centralized Ex-Vivo Lung Evaluation System (EVLP)

DRUG/DEVICE
Centralized Lung Evaluation System
ROUTE OF ADMINISTRATION
Device
THERAPEUTIC PLATFORM
Organ Manufacturing
CLINICAL TRIAL
TERRITORY
Approximately 3,600 end-stage lung disease patients nationally are awaiting a transplant among 70 adult lung transplant centers in the U.S. Lung Bioengineering locations in Silver Spring, Maryland and Jacksonville, Florida have the ability to provide EVLP services to approximately 60% of U.S. adult lung transplant centers.
STATUS
Pivotal Trial
CAUTION: Investigational device. Limited by Federal law to investigational use.